Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Clark

Showing results (1371-1380 of 1,669) with videos related to

Pageof 167
Sort By:
British Journal of Cancer|June 30, 2005
A phase I clinical trial of continual alternating etoposide and topotecan in refractory solid tumoursR T Penson, M V Seiden, U A Matulonis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1990
Treatment of hairy cell leukemia with alternating cycles of pentostatin and recombinant leukocyte A interferon: results of a phase II studyA Martin, S Nerenstone, W J Urba, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|February 11, 2026
Surfactant nebulization in severe COVID-19: Tracheal aspirate phospholipid turnover and metabolismAnthony D Postle, Howard W Clark, James Fink, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1984
Lentigo maligna melanoma has no better prognosis than other types of melanomaH K Koh, E Michalik, A J Sober, et al.
Cancer Chemotherapy and Pharmacology|December 20, 2005
Phase I clinical trial of the farnesyltransferase inhibitor BMS-214662 administered as a weekly 24 h continuous intravenous infusion in patients with advanced solid tumorsJoseph P Eder, David P Ryan, Leonard Appleman, et al.
Journal of the National Cancer Institute|June 17, 1992
Pilot study of interleukin-2 and lymphokine-activated killer cells combined with immunomodulatory doses of chemotherapy and sequenced with interferon alfa-2a in patients with metastatic melanoma and renal cell carcinomaM Sznol, J W Clark, J W Smith, et al.
Journal of Digital Imaging|September 9, 2008
Collecting 48,000 CT exams for the lung screening study of the National Lung Screening TrialKenneth W Clark, David S Gierada, Guillermo Marquez, et al.
Journal of the National Cancer Institute|April 19, 1989
Intraperitoneal lymphokine-activated killer cell/interleukin-2 therapy in patients with intra-abdominal cancer: immunologic considerationsW J Urba, J W Clark, R G Steis, et al.
Clinical Colorectal Cancer|March 18, 2004
Dihydropyrimidine dehydrogenase and thymidylate synthase polymorphisms and their association with 5-fluorouracil/leucovorin chemotherapy in colorectal cancerAndrew X Zhu, Thomas A Puchalski, Vincent P Stanton, et al.
Nature Communications|December 31, 2024
Small-angle scattering interferometry with neutron orbital angular momentum statesDusan Sarenac, Melissa E Henderson, Huseyin Ekinci, et al.
Pageof 167

Showing results (1371-1380 of 1,669) with videos related to

Sort By:
Pageof 167
British Journal of Cancer|June 30, 2005
A phase I clinical trial of continual alternating etoposide and topotecan in refractory solid tumoursR T Penson, M V Seiden, U A Matulonis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1990
Treatment of hairy cell leukemia with alternating cycles of pentostatin and recombinant leukocyte A interferon: results of a phase II studyA Martin, S Nerenstone, W J Urba, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|February 11, 2026
Surfactant nebulization in severe COVID-19: Tracheal aspirate phospholipid turnover and metabolismAnthony D Postle, Howard W Clark, James Fink, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1984
Lentigo maligna melanoma has no better prognosis than other types of melanomaH K Koh, E Michalik, A J Sober, et al.
Cancer Chemotherapy and Pharmacology|December 20, 2005
Phase I clinical trial of the farnesyltransferase inhibitor BMS-214662 administered as a weekly 24 h continuous intravenous infusion in patients with advanced solid tumorsJoseph P Eder, David P Ryan, Leonard Appleman, et al.
Journal of the National Cancer Institute|June 17, 1992
Pilot study of interleukin-2 and lymphokine-activated killer cells combined with immunomodulatory doses of chemotherapy and sequenced with interferon alfa-2a in patients with metastatic melanoma and renal cell carcinomaM Sznol, J W Clark, J W Smith, et al.
Journal of Digital Imaging|September 9, 2008
Collecting 48,000 CT exams for the lung screening study of the National Lung Screening TrialKenneth W Clark, David S Gierada, Guillermo Marquez, et al.
Journal of the National Cancer Institute|April 19, 1989
Intraperitoneal lymphokine-activated killer cell/interleukin-2 therapy in patients with intra-abdominal cancer: immunologic considerationsW J Urba, J W Clark, R G Steis, et al.
Clinical Colorectal Cancer|March 18, 2004
Dihydropyrimidine dehydrogenase and thymidylate synthase polymorphisms and their association with 5-fluorouracil/leucovorin chemotherapy in colorectal cancerAndrew X Zhu, Thomas A Puchalski, Vincent P Stanton, et al.
Nature Communications|December 31, 2024
Small-angle scattering interferometry with neutron orbital angular momentum statesDusan Sarenac, Melissa E Henderson, Huseyin Ekinci, et al.
Pageof 167